rxstat › Shortages › Oxcarbazepine

Oxcarbazepine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Oxcarbazepine products are in shortage in Canada (3 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 30, 2022.
Products affected
3 / 8
In shortage since
Oct 12, 2018
Est. full return
Dec 30, 2022
Reports on file
18
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
JAMP-OXCARBAZEPINE
600MG · TABLET · JAMP PHARMA CORPORATION
DIN 02440733 · since Oct 12, 2018, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-OXCARBAZEPINE
300MG · TABLET · JAMP PHARMA CORPORATION
DIN 02440725 · since Oct 12, 2018, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-OXCARBAZEPINE
150MG · TABLET · JAMP PHARMA CORPORATION
DIN 02440717 · since Oct 12, 2018, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Resolved
APO-OXCARBAZEPINE
300MG · TABLET · APOTEX INC
DIN 02284308 · ended May 9, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-OXCARBAZEPINE
150MG · TABLET · APOTEX INC
DIN 02284294 · ended May 9, 2024 · Disruption of the manufacture of the drug.
Resolved
TRILEPTAL 600 MG
600MG · TABLET · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02242069 · ended Feb 8, 2023 · Disruption of the manufacture of the drug.
Resolved
TRILEPTAL 300 MG
300MG · TABLET · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02242068 · ended Feb 3, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-OXCARBAZEPINE
600MG · TABLET · APOTEX INC
DIN 02284316 · ended May 20, 2022 · Disruption of the manufacture of the drug.
Resolved
APO-OXCARBAZEPINE
600MG · TABLET · APOTEX INC
DIN 02284316 · ended Feb 8, 2022 · Shortage of an active ingredient.
Resolved
APO-OXCARBAZEPINE
150MG · TABLET · APOTEX INC
DIN 02284294 · ended Feb 8, 2022 · Shortage of an active ingredient.
Resolved
APO-OXCARBAZEPINE
300MG · TABLET · APOTEX INC
DIN 02284308 · ended Feb 8, 2022 · Shortage of an active ingredient.
Avoided
TRILEPTAL 600 MG
600MG · TABLET · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02242069 · ended Dec 3, 2020 · Demand increase for the drug.

Showing 12 of 18 reports. All reports are on file with Health Canada.

What's happening

Oxcarbazepine is currently affected by 3 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Oxcarbazepine is classified under “ANTIEPILEPTICS” (ATC N03AF).

Recent changes

Common questions

When will Oxcarbazepine be back in stock in Canada?

The latest manufacturer estimate is Dec 30, 2022. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Oxcarbazepine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiepileptics)

Partial shortageBrivaracetam1 of 8 reported products affected · est. return Apr 3, 2026Partial shortageCarbamazepine2 of 20 reported products affected · est. return Jun 26, 2026Partial shortageClonazepam5 of 21 reported products affectedPartial shortageLacosamide6 of 34 reported products affected · est. return Aug 10, 2026Partial shortageLevetiracetam13 of 48 reported products affected · est. return Sep 11, 2026Partial shortagePerampanel1 of 8 reported products affected · est. return Jul 3, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.